IDXX
IDEXX Laboratories Inc
NASDAQ: IDXX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$553.66
-2.58% today
Updated 2026-04-29
Market cap
$44.08B
P/E ratio
42.36
P/S ratio
10.24x
EPS (TTM)
$13.07
Dividend yield
—
52W range
$465 – $770
Volume
0.5M
IDEXX Laboratories Inc (IDXX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $739.12M | $922.55M | $1.02B | $1.03B | $1.10B | $1.22B | $1.29B | $1.38B | $1.49B | $1.60B | $1.78B | $1.97B | $2.21B | $2.41B | $2.71B | $3.22B | $3.37B | $3.66B | $3.90B | $4.30B |
| Revenue growth (YoY) | — | +24.8% | +11.0% | +0.7% | +7.0% | +10.4% | +6.1% | +6.5% | +7.9% | +7.8% | +10.8% | +10.9% | +12.4% | +8.8% | +12.5% | +18.8% | +4.7% | +8.7% | +6.5% | +10.4% |
| Cost of revenue | $359.59M | $459.03M | $494.26M | $505.35M | $524.77M | $572.18M | $594.19M | $620.94M | $669.69M | $711.62M | $799.99M | $871.68M | $971.70M | $1.04B | $1.14B | $1.33B | $1.36B | $1.47B | $1.52B | $1.64B |
| Gross profit | $379.53M | $463.52M | $529.77M | $526.28M | $578.62M | $646.51M | $699.15M | $756.12M | $816.12M | $890.27M | $975.44M | $1.10B | $1.24B | $1.37B | $1.57B | $1.89B | $2.00B | $2.19B | $2.38B | $2.66B |
| Gross margin | 51.3% | 50.2% | 51.7% | 51.0% | 52.4% | 53.0% | 54.1% | 54.9% | 54.9% | 55.6% | 54.9% | 55.7% | 56.1% | 56.7% | 58.0% | 58.8% | 59.5% | 59.8% | 61.0% | 61.8% |
| R&D | $53.62M | $67.34M | $70.55M | $65.12M | $68.60M | $76.04M | $82.01M | $88.00M | $98.26M | $99.68M | $101.12M | $109.18M | $117.86M | $133.19M | $141.25M | $161.01M | $254.82M | $190.95M | $219.79M | $251.21M |
| SG&A | $82.10M | $108.12M | $115.59M | $117.44M | $126.52M | $129.39M | $137.61M | $157.86M | $173.89M | $182.51M | $207.02M | $220.88M | $244.94M | $261.32M | $300.83M | $309.66M | $326.25M | $335.82M | $442.29M | $404.79M |
| Operating income | $127.93M | $136.18M | $172.46M | $175.97M | $203.88M | $236.22M | $262.56M | $266.76M | $260.25M | $299.91M | $350.24M | $413.03M | $491.33M | $552.85M | $694.52M | $932.03M | $898.76M | $1.10B | $1.13B | $1.36B |
| Operating margin | 17.3% | 14.8% | 16.8% | 17.1% | 18.5% | 19.4% | 20.3% | 19.4% | 17.5% | 18.7% | 19.7% | 21.0% | 22.2% | 23.0% | 25.7% | 29.0% | 26.7% | 30.0% | 29.0% | 31.6% |
| EBITDA | $157.75M | $177.28M | $221.28M | $225.74M | $249.84M | $284.43M | $314.97M | $321.36M | $319.14M | $370.29M | $428.46M | $496.17M | $574.51M | $640.86M | $790.52M | $1.04B | $1.01B | $1.10B | $1.28B | $1.47B |
| EBITDA margin | 21.3% | 19.2% | 21.6% | 21.9% | 22.6% | 23.3% | 24.4% | 23.3% | 21.5% | 23.1% | 24.1% | 25.2% | 26.0% | 26.6% | 29.2% | 32.2% | 30.0% | 30.0% | 32.7% | 34.1% |
| EBIT | $127.93M | $136.18M | $172.46M | $175.97M | $203.88M | $236.22M | $262.56M | $266.76M | $260.25M | $301.34M | $350.24M | $413.03M | $491.33M | $552.85M | $694.52M | $932.03M | $898.76M | $1.10B | $1.15B | $1.36B |
| Interest expense | $462000.00 | $4.18M | $4.59M | $1.43M | $1.75M | $1.80M | $1.95M | $3.50M | $13.70M | $29.24M | $28.39M | $31.97M | $33.59M | $30.63M | $32.54M | $29.37M | $38.79M | $35.95M | $31.20M | $38.27M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $93.68M | $94.01M | $116.17M | $122.22M | $141.28M | $161.79M | $178.27M | $187.80M | $181.91M | $192.08M | $222.04M | $263.14M | $377.03M | $427.72M | $581.78M | $744.85M | $679.09M | $845.04M | $887.87M | $1.06B |
| Net income growth (YoY) | — | +0.4% | +23.6% | +5.2% | +15.6% | +14.5% | +10.2% | +5.3% | -3.1% | +5.6% | +15.6% | +18.5% | +43.3% | +13.4% | +36.0% | +28.0% | -8.8% | +24.4% | +5.1% | +19.3% |
| Profit margin | 12.7% | 10.2% | 11.3% | 11.8% | 12.8% | 13.3% | 13.8% | 13.6% | 12.2% | 12.0% | 12.5% | 13.4% | 17.0% | 17.8% | 21.5% | 23.2% | 20.2% | 23.1% | 22.8% | 24.6% |